دورية أكاديمية

Mesenchymal Hamartoma of the Liver and DICER1 Syndrome.

التفاصيل البيبلوغرافية
العنوان: Mesenchymal Hamartoma of the Liver and DICER1 Syndrome.
المؤلفون: Apellaniz-Ruiz, Maria1,2, Segni, Maria3, Kettwig, Matthias4, Glüer, Sylvia5, Pelletier, Dylan2,6, Nguyen, Van-Hung7, Wagener, Rabea8, López, Cristina8, Muchantef, Karl9, Bouron-Dal Soglio, Dorothée10, Sabbaghian, Nelly2, Wu, Mona K.1,2, Zannella, Stefano11, Fabian, Marc R.2,12,13, Siebert, Reiner8, Menke, Jan14, Priest, John R.15, Foulkes, William D.1,2,12,16
المصدر: New England Journal of Medicine. 5/9/2019, Vol. 380 Issue 19, p1834-1842. 9p.
مستخلص: Mesenchymal hamartoma of the liver (MHL) is a benign tumor affecting children that is characterized by a primitive myxoid stroma with cystically dilated bile ducts. Alterations involving chromosome 19q13 are a recurrent underlying cause of MHL; these alterations activate the chromosome 19 microRNA cluster (C19MC). Other cases remain unexplained. We describe two children with MHLs that harbored germline DICER1 pathogenic variants. Analysis of tumor tissue from one of the children revealed two DICER1 "hits." Mutations in DICER1 dysregulate microRNAs, mimicking the effect of the activation of C19MC. Our data suggest that MHL is a new phenotype of DICER1 syndrome. (Funded by the Canadian Institutes of Health Research and others.). [ABSTRACT FROM AUTHOR]
قاعدة البيانات: Academic Search Index
الوصف
تدمد:00284793
DOI:10.1056/NEJMoa1812169